Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1998-06-30
2000-02-29
Wilson, James O.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 49, 514 50, 514885, 536 261, 536 268, 536 282, C07H 19073, A61K 3170, A61K 3117
Patent
active
060309571
ABSTRACT:
Aryl phosphate derivatives of d4T with para-bromo substitution on the aryl group show markedly increased potency as anti-HIV agents without undesirable levels of cytotoxic activity. In particular, these derivatives are potent inhibitors of HIV reverse transcriptase. In a preferred aspect of the present invention, the phosphorus of the aryl phosphate group is further substituted with an amino acid residue that may be esterified or substituted, such as a methoxy alaninyl group.
REFERENCES:
patent: 5659023 (1997-08-01), Alexander et al.
patent: 5672698 (1997-09-01), Chen et al.
patent: 5750729 (1998-05-01), Alexander et al.
Vig et al., Antiviral Chem. Chemother., vol. 9(5), pp. 445-448, 1998.
Alexander et al., "Synthesis and Antiviral Activity of Pyranosylphosphonic Acid Nuceotide Analogues", J. Med. Chem., 39:1321-1330, 1996.
M.M. Mansuri et al., J. of Med. Chem., vol. 32(2), pp. 461-466, 1989.
McGuigane et al.,, J. Med. Chem., vol. 39, p. 1748, 1996.
Uckun Fatih M.
Vig Rakesh
Owens Howard
Wayne Hughes Institute
Wilson James O.
LandOfFree
Aryl phosphate derivatives of d4T having anti-HIV activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl phosphate derivatives of d4T having anti-HIV activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl phosphate derivatives of d4T having anti-HIV activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-683106